[Circulating Levels of Estradiol in Breast Cancer Patients Treated with Aromatase Inhibitors and Their Clinical Implications].

Petráková, K; Krásenská, M; Valík, D; Holánek, M; Palácová, M; Demlová, R

[Circulating Levels of Estradiol in Breast Cancer Patients Treated with Aromatase Inhibitors and Their Clinical Implications]. / Sledování cirkulujících hladin estradiolu u pacientek s karcinomem prsu lécených inhibitory aromatázy - prínos v klinické praxi.

Petráková, K; Krásenská, M; Valík, D; Holánek, M; Palácová, M; Demlová, R.

Klin Onkol ; 29 Suppl 3: S50-57, 2016.

Article in Cs | MEDLINE | ID: mdl-28118724

Subject(s)

Antineoplastic Agents, Hormonal/adverse effects; Aromatase Inhibitors/adverse effects; Breast Neoplasms/drug therapy; Estradiol/blood; Antineoplastic Agents, Hormonal/therapeutic use; Aromatase Inhibitors/therapeutic use; Chemotherapy, Adjuvant; Female; Humans; Tamoxifen

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents, Hormonal / Aromatase Inhibitors / Estradiol Type of study: Guideline Limits: Female / Humans Language: Cs Journal: Klin Onkol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: Czech Republic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google